selected scholarly activity
-
chapters
- Chapter 27 Gastrointestinal Microbiota and the Neural System. 243-247. 2017
- Gastrointestinal Microbiota and the Neural System. 243-247. 2017
- The Effects of Inflammation, Infection and Antibiotics on the Microbiota-Gut-Brain Axis. Advances in Experimental Medicine and Biology. 279-289. 2014
-
conferences
- MICROBIOTA FROM PATIENTS WITH CROHN'S DISEASE INDUCES BEHAVIOURAL CHANGES IN MICROBIOTA-HUMANIZED MICE. Gastroenterology. S87-S87. 2023
- REVERSAL OF SEVERE GUT DYSFUNCTION FOLLOWING CLOSTRIDIUM DIFFICILE INFECTION BY MICROBIOTA-DIRECTED DIETARY INTERVENTION. Gastroenterology. S258-S259. 2023
- ROLE OF GUT MICROBIOTA IN SYMPTOM EPISODES OF IRRITABLE BOWEL SYNDROME. Gastroenterology. S1057-S1057. 2023
- Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Critical Care Medicine. 1175-1186. 2022
- Investigating the interaction between the human gut microbiome and clozapine therapy in schizophrenia. Journal of Psychiatry & Neuroscience. S23-S23. 2022
- GUT MICROBIOTA MODULATES CGRP PRODUCTION BY DRG NEURONS IN FEMALE MICE. Gastroenterology. S761-S761. 2022
- The Fecal Microbiome Differences Between Patients With Systemic Sclerosis With And Without Small Intestinal Bacterial Overgrowth. Journal of Rheumatology. 1182-1183. 2021
- DORSAL ROOT GANGLIA (DRG) NEURONAL RESPONSES AND SUBSTANCE P PRODUCTION ARE HIGHER IN MALE MICE AND SIMILAR BETWEEN CONVENTIONAL AND GERM-FREE MICE. Gastroenterology. S148-S148. 2021
- PROINFLAMMATORY EFFECT OF HIGH SALT DIET AND UC MICROBIOTA IN GNOTOBIOTIC MICE. Gastroenterology. S566-S567. 2021
- The Role of the Microbiome-Gut-Brain Axis in Schizophrenia and Clozapine-Induced Weight Gain. Biological Psychiatry. S342-S342. 2021
- ARYL HYDROCARBON RECEPTOR LIGAND PRODUCTION BY THE GUT MICROBIOTA IN CELIAC DISEASE. Gastroenterology. S217-S217. 2020
- CHARACTERISTICS OF SKIN LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY OR OTHER BIOLOGIC AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY. Gastroenterology. S675-S676. 2020
- EVALUATION OF GUT MICROBIOTA COMPOSITION IN NAFLD WITH UC PANCOLITIS IN CLINICAL REMISSION: A PILOT STUDY. Gastroenterology. S547-S548. 2020
- SACCHAROMYCES BOULARDII CNCM I-745 IMPROVES GUT-BRAIN AXIS DYSFUNCTION IN A HUMANIZED MOUSE MODEL OF IRRITABLE BOWEL SYNDROME WITH CO-MORBID ANXIETY. Gastroenterology. S150-S150. 2020
- THE ASSOCIATION BETWEEN INFLAMMATORY BOWEL DISEASE AND CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology. S1002-S1003. 2020
- THE INFLUENCE OF SEX AND THE GUT MICROBIOTA ON VISCERAL SENSITIVITY IN MICE. Gastroenterology. S553-S553. 2020
- THE INTESTINAL MICROBIOTA FROM A PATIENT WITH IBS-C SLOWS MOUSE COLONIC TRANSIT BY DISRUPTING INTERSTITIAL CELL OF CAJAL NETWORK. Gastroenterology. S899-S900. 2020
- Metabolomic and microbial profiles identify subsets of diarrhea predominant irritable bowel syndrome. Neurogastroenterology and Motility. 2020
- Distinct Characteristics of the Gut Microbiome of Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth. Arthritis & Rheumatology. 2019
- A LONGITUDINAL STUDY EXAMINING THE EFFECT OF ALTERING FODMAP INTAKE ON THE METABOLOME AND PAIN SIGNALLING IN IBS PATIENTS. Gastroenterology. S570-S571. 2019
- LACK OF EXPERIMENTAL REPRODUCIBILITY IN PRECLINICAL RESEARCH MAY BE INFLUENCED BY THE NUTRITIONAL PROFILE OF STANDARD RODENT CHOWS. Gastroenterology. S481-S481. 2019
- METABOLISM OF WHEAT AMYLASE TRYPSIN INHIBITORS BY LACTOBACILLI AMELIORATES GUT DYSFUNCTION INDUCED BY WHEAT PROTEINS. Gastroenterology. S174-S175. 2019
- MICROBIOTA PLAYS A KEY ROLE IN FORMATION OF NORMAL INTESTINAL MOTOR PATTERNS. Gastroenterology. S198-S198. 2019
- O54. The Effect of Gut Microbiota on Glutamatergic/GABAergic Gene Expression in Adult Mice. Biological Psychiatry. S127-S128. 2019
- Abstract # 3094 Microbiota-neuroimmune interactions in a humanized mouse model of IBS: The role of diet and mast cells. Brain, Behavior, and Immunity. e15-e16. 2019
- Beliefs and Practices of Canadian and US Physicians Regarding the Use of Probiotics for Gastrointestinal Illnesses. American Journal of Gastroenterology. S252-S253. 2018
- GUT MICROBIOTA DEFINES HOST RESPONSES TO DIETARY FERMENTABLE CARBOHYDRATES IN IBS: THE ROLE OF BACTERIAL HISTAMINE. Gastroenterology. S565-S565. 2018
- GUT MICROBIOTA-DIET INTERACTIONS IN A HUMANIZED MOUSE MODEL OF IBS: THE ROLE OF INTESTINAL MAST CELLS. Gastroenterology. S182-S182. 2018
- MICROBIOTA FROM IBS-D PATIENTS INDUCES DYSREGULATION OF INNATE IMMUNITY. Gastroenterology. S193-S193. 2018
- THE PREVALENCE OF CELIAC DISEASE IS INCREASED IN PATIENTS WITH BARRETT'S ESOPHAGUS AND IS ASSOCIATED WITH EARLY DEVELOPMENT OF DYSPLASIA. Gastroenterology. S680-S680. 2018
- T192. THE GUT MICROBIOME IN SCHIZOPHRENIA AND ANTIPSYCHOTIC INDUCED METABOLIC DYSFUNCTION. Schizophrenia Bulletin. S190-S191. 2018
- ANTIGLIADIN ANTIBODIES PREDICT THE SYMPTOMATIC RESPONSE TO GLUTEN-FREE DIET AND IMPROVEMENT IN GASTROINTESTINAL MOTILITY IN IBS PATIENTS. Gastroenterology. S45-S45. 2017
- Diet-Microbiota Interactions Underlie Symptoms' Generation in IBS. Gastroenterology. S160-S160. 2017
- Gluten Free Diet Improves Upper GI Symptoms and Promotes Changes in Gastric Emptying in IBS Patients with Functional Dyspepsia. Gastroenterology. S939-S939. 2017
- No Detrimental Effect of Oats on Symptoms, Histological Parameters, Serological Tests, or Quality of Life in Celiac Disease: A Systematic Review and Meta-Analysis. Gastroenterology. S481-S481. 2017
- Nutritional Wheat Amylase Trypsin Inhibitors Exacerbate Gluten-Induced Pathology and Alter the Gut Microbiota in Mice. Gastroenterology. S71-S71. 2017
- beta 2-1 Fructan Supplementation in Healthy Adults Elicits Host-Specific Bacterial Responses But Does Not Support a Defined Health Benefit. The FASEB Journal. 2017
- EFFECT OF DIET ON GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) STRATIFIED BY ANTIGLIADIN (AGA) ANTIBODIES. Annals of Nutrition and Metabolism. 1018-1018. 2017
- Abstract # 1849 The role of immune system maturation in development of normal behavior in mice. Brain, Behavior, and Immunity. e39-e39. 2016
- Abstract # 1850 Early life stress predisposes to increased sensitivity to inflammatory stimuli through intestinal dysbiosis. Brain, Behavior, and Immunity. e39-e39. 2016
- The central role of the intestinal microbiota in chronic intestinal pseudo-obstruction. Neurogastroenterology and Motility. 16-16. 2016
- 258 FODMAPs Alter the Metabolome and Symptoms in Irritable Bowel Syndrome Patients. Gastroenterology. S62-S63. 2016
- 616 Metabolomic Profiling Differentiates Irritable Bowel Syndrome Patients From Healthy Controls and Ulcerative Colitis Patients. Gastroenterology. S126-S126. 2016
- Mo1653 Improvement of Gastrointestinal Symptoms After Gluten-Free Diet in Patients With Irritable Bowel Syndrome Is Dependent on the Presence of Anti-Gliadin Antibodies. Gastroenterology. S743-S744. 2016
- Su1901 High Salt Diet Increases Susceptibility to Experimental Colitis: A Putative Role of Gut Microbiota. Gastroenterology. S583-S583. 2016
- Adrenergic Innervation Regulates Intestinal Microbiota Diversity and Richness via Cholinergic Th17 Lymphocytes. Gastroenterology. S20-S20. 2015
- Anxiety and Depression Increase in a Step-Wise Fashion in Parallel With Multiple FGIDs. Gastroenterology. S654-S654. 2015
- Increased Risk of Functional Gastrointestinal Disorders (FGIDs) in Obesity Patients. Gastroenterology. S672-S673. 2015
- Reflux Symptoms in Patients With Celiac Disease Are Associated With Alkaline or Weakly Acid Reflux. Gastroenterology. S284-S284. 2015
- Dermatological Complications of Anti-TNF-alpha Therapy in Crohn's Disease. Gastroenterology. S583-S583. 2014
- Faecalibacterium prausnitzii Prevents Irritable Bowel Syndrome-Like Symptoms in Both Murine Low Grade Chronic Inflammation and Acute Stress Models. Gastroenterology. S840-S841. 2014
- Increased Prevalence of Gluten Related Disorders in Patients With Barrett's Esophagus: The Impact on the Development of Dysplasia. Gastroenterology. S470-S471. 2014
- Larazotide Acetate, a First In-Class, Novel Tight Junction Regulator, Meets Primary Endpoint and Significantly Reduces Signs and Symptoms of Celiac Disease in Patients on a Gluten-Free Diet: Results of a Multicenter, Randomized, Placebo Controlled Trial. Gastroenterology. S159-S159. 2014
- The Adoptive Transfer of Anxiety and Gut Dysfunction From IBS Patients to Axenic Mice Through Microbiota Transplantation. Gastroenterology. S845-S845. 2014
- The Critical Role of Gut Microbiota in Determining Behavioral Changes and Susceptibility to Inflammation in a Model of Depression. Gastroenterology. S7-S7. 2014
- The Effect of High Fat Diet on Human Microbiota Transfer Into Gnotobiotic Mice. Gastroenterology. S8-S9. 2014
- Transplantation of Dysbiotic Microbiota Derived From UC Patients Promotes a Pro-Inflammatory Phenotype and Increased Susceptibility of Gnotobiotic Mice to Colitis. Gastroenterology. S23-S23. 2014
- 50. Cytokine. 255-255. 2013
- Bifidobacterium Breve NCC2950 Induces Expression of Antimicrobial Regiii in Colonic Epithelial Cells Through MYD88-Ticam Pathway. Gastroenterology. S894-S895. 2013
- Impact of the Commensal Bacterium Faecalibacterium prausnitzii in a Non Active Inflammation Murine Model. Gastroenterology. S897-S898. 2013
- Interstitial cells of Cajal and their association with enteric nerves in human gastro-duodenal junction. Neurogastroenterology and Motility. 156-156. 2012
- Intestinal microbiota in the neuro-immune regulation of behaviour: Exploring role of vagal-microbiota signalling. Neurogastroenterology and Motility. 78-78. 2012
- Microbial colonization of germ-free mice induces marked change in behaviour that is independent of bacterial diversity. Neurogastroenterology and Motility. 77-77. 2012
- The critical role of microbiota in the expression of altered behavior in mice subjected to maternal separation. Neurogastroenterology and Motility. 42-42. 2012
- Transfer of IBS phenotype to GERM-free mice through microbiota transplantation. Neurogastroenterology and Motility. 33-33. 2012
- Ultra performance liquid chromatography–tandem mass spectrometry determination of tryptophan metabolites. Clinical Biochemistry. 1122-1123. 2012
- A Novel In Vivo Method to Measure Gastrointestinal Transit in Mice. Gastroenterology. S897-S897. 2012
- Immediate Effects of Infliximab Infusion on Mood in Patients With Inflammatory Bowel Disease. Gastroenterology. S69-S69. 2012
- Protective and Curative Effect of Faecalibacterium prausnitzii in a Chronic DNBS-Induced Murine Colitis. Gastroenterology. S392-S392. 2012
- The Role of Microbiota in the Maternal Separation Model of Depression. Gastroenterology. S554-S554. 2012
- Characterizing the Neural Pathways of Communication Within the Microbiota-Gut-Brain Axis. Gastroenterology. S362-S362. 2011
- Proton Pump Inhibitors and Low-Dose Aspirin Markedly Exacerbate NSAID-Induced Small Intestinal Injury: A Link to Dysbiosis?. Gastroenterology. S87-S87. 2011
- The Anxiolytic Effect of Bifidobacterium Longum Ncc3001 Requires Vagal Integrity for Gut-Brain Communication. Gastroenterology. S18-S19. 2011
- The Intestinal Microbiota Determines Mouse Behavior and Brain BDNF Levels. Gastroenterology. S57-S57. 2011
- A flexible continuum between adaptive and innate immunity in host-microbiota mutualism. Swiss Medical Weekly. 15S-15S. 2009
- Antibiotic-Induced Intestinal Dysbiosis Results in Altered Behavior in BALB/C Mice. Gastroenterology. A776-A777. 2009
- Early Depression-Like Behaviour in Maternal Separation Mice Is Associated with Altered Microbiota. Gastroenterology. A703-A703. 2009
- Examination of the Depressed Gut Reveals Changes in Microbiota and Serotonin Levels. Gastroenterology. A575-A575. 2009
- Neonatal Stress Induces Changes in the Enteric Nervous System and Gut Microflora. Gastroenterology. A273-A273. 2009
- Delayed Retroperitoneal Perforation in Patient on Immunosuppresive Treatment. American Journal of Gastroenterology. S525-S525. 2008
- Altered intestinal paracellular permeability in H-pylori infected mice is restored by bacterial eradication and probiotic treatment. Gastroenterology. A691-A691. 2008
- Effects of probiotics on gut-brain axis during chronic H-pylori infection. Gastroenterology. A97-A97. 2008
- Accelerate reversal of helicobacter pylori-induced gastric dysfunction by specific probiotics through an anti-inflammatory effect. Gastroenterology. A626-A626. 2006
- Post-infective changes in behavior: A model of functional dyspepsia in the mouse. Gastroenterology. A439-A439. 2006
- Depression enhances vulnerability to experimental colitis in maternally deprived mice.. Gastroenterology. A623-A623. 2005
- Immune cells modulate visceral pain by endogenous opioid production.. Gastroenterology. A225-A225. 2005
- Immunodeficiency and visceral hyperalgesia: A putative mechanism for abdominal pain in AIDS patients. Gastroenterology. A161-A161. 2004
- Lactobacillus paracasei normalizes post-infective dysmotility in vivo and induces a sustained attenuation of inflammatory mediators. Gastroenterology. A170-A170. 2004
- Previous Helicobacter pylori (Hp) infection and functional dyspepsia; a role for cellular rather than humoral immune activation in the maintenance of gastric motor dysfunction. Gastroenterology. A484-A485. 2004
- Videofluoroscopy and image analysis: A new method for the simultaneous assessment of gastric emptying and upper gastrointestinal (GI) motility in humans. Gastroenterology. A350-A350. 2004
- Behavioral abnormalities and increased local and systemic inflammatory responses in adult mice following maternal deprivation as neonates. Gastroenterology. A667-A668. 2003
- Magnet-tracing (MT) in the gastrointestinal (GI) tract: a new technique for non-invasive verification of nasogastric tube (NGT) placement. Gastroenterology. A24-A25. 2003
- Neuronal remodeling and immune activation maintains gut dysfunction in a model of post-infective IBS. Gastroenterology. A346-A346. 2003
- Orocecal transit times (OCTT) in healthy subjects assessed by magnet-tracing (MT) and lactulose breath hydrogen test (LBHT). Gastroenterology. A426-A426. 2003
- Strain-dependent effects of probiotics on intestinal muscle dysfunction in an animal model of post-infective irritable bowel syndrome. Gastroenterology. A29-A29. 2003
- Putative role of Helicobacter antigen in functional dyspepsia: a conceptual model. HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2002. 83-88. 2003
- Estrogen increases the severity of dextran sodium sulfate colitis through a mechanism that is independent of macrophage colony stimulating factor-1 (M-CSF-1). Gastroenterology. A263-A263. 2002
- On the relationship of IBS and IBD: Estrogen induces a sustained increase in colonic substance P levels post DNB colitis.. Gastroenterology. A135-A135. 2002
- Persistence of sensory and eating disturbances after H-pylori eradication in mice. Gastroenterology. A561-A561. 2002
- Psychosocial and environmental determinants of post-infective gut dysfunction in the mouse. Gastroenterology. A503-A503. 2002
- The relationship between chronic colonic inflammation and mechanosensitivity.. Gastroenterology. A528-A528. 2002
- Chronic H. pylori interaction induces functional and morphological changes in the neural system. Gastroenterology. A235-A235. 2001
- Estrogen decreases the acute inflammatory response in DNB-induced colitis in C57 BL/6 mice. Gastroenterology. A688-A688. 2001
- In Vivo motility disturbances in a model of post-infective IBS. Gastroenterology. A71-A71. 2001
- Neuro-immune interactions in the stomach of H. pylori infected mice: Role of lymphocytes. Gastroenterology. A535-A535. 2001
- Association of family history of gastric cancer, intestinal metaplasia and high gastric juice ammonia in patients with Helicobacter pylori infection. Gastroenterology. A1216-A1216. 2000
- Helicobacter pylori infection delays gastric emptying in mice. Gastroenterology. A148-A148. 2000
- Helicobacter pylori infection induces in vitro evidence of neural dysfunction in the murine gastric antrum. Gastroenterology. A737-A737. 2000
- Current concepts of dyspepsia: the role of the nervous system. HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000. 411-420. 2000
- Dexanabinol enema reduces the severity of experimental colitis in rats. Gastroenterology. A686-A686. 1999
- Disturbed in vivo motor patterns in Trichinella spiralis infected mice. Gastroenterology. A974-A974. 1999
- Oral administration of intestinalflora antigens consisting of anaerobes reduces the severity of experimental acute colitis in BALB c mice. Gastroenterology. A775-A775. 1999
- Effector mechanisms in intestinal immunity and inflammation. INNOVATIVE CONCEPTS IN INFLAMMATORY BOWEL DISEASES. 74-83. 1999
- Oral administration of intestinal flora sonicate reduces severity of DDS-induced acute colitis in BALB/C mice. Gastroenterology. A1109-A1109. 1998
- Preservation of the rat ileum by perfusion with fluorocarbon vs erythrocyte based oxygen carriers. Artificial Cells Blood Substitutes and Biotechnology. 82. 1998
- Apparent increase in acid output during omeprazole (OME) after cure of H-pylori infection (HpI).. Gastroenterology. A70-A70. 1997
- H-pylori related increase in omeprazole (OME) effect is associated with ammonia production.. Gastroenterology. A64-A64. 1996
- Production of volatile amines by Helicobacter pylori (HP) is not relevant in vivo.. Gastroenterology. A285-A285. 1996
- The role of VIP in the control of motor patterns of the rat ileum in vitro. Gastroenterology. A639-A639. 1996
- INTERPLAY OF VIP, NITRIC-OXIDE AND MOTOR PATTERNS OF THE RAT ILEUM IN-VITRO. Gastroenterology. A570-A570. 1995
- IDENTIFICATION OF AREAS INDUCING RHYTHMIC MYOGENIC ACTIVITY BY IMAGE-ANALYSIS OF RAT ILEUM IN-VITRO. Gastroenterology. A491-A491. 1994
- LUMINAL DISTENSION, MOTILITY PATTERNS AND LUMINAL TRANSPORT IN ISOLATED ARTERIALLY PERFUSED RAT ILEUM. Gastroenterology. A476-A476. 1993
- MECHANICAL CORRELATES OF INTESTINAL FLUID-FLOW IN AN ISOLATED ARTERIALLY PERFUSED RAT ILEUM. Gastroenterology. A476-A476. 1993
- THE ROLE OF THE ENS IN SMALL INTESTINAL MOTILITY - STUDIES IN AN ISOLATED ARTERIALLY-PERFUSED LOOP INVITRO. European Journal of Neuroscience. 147-147. 1992
-
journal articles
- Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic. Gut Microbes. 16:2347715. 2024
- Human-fecal microbiota transplantation in relation to gut microbiome signatures in animal models for schizophrenia: A scoping review.. Asian Journal of Psychiatry. 102:104285. 2024
- Gluten-Dependent Activation of CD4+ T Cells by MHC Class II–Expressing Epithelium. Gastroenterology. 167:1113-1128. 2024
- Oral tryptophan activates duodenal aryl hydrocarbon receptor in healthy subjects: a crossover randomized controlled trial. American Journal of Physiology - Gastrointestinal and Liver Physiology. 326:G687-G696. 2024
- 16 INFLAMMATORY BOWEL DISEASE (IBD)-ASSOCIATED MICROBIOTA ALTER VISCERAL SENSITIVITY AND BEHAVIOUR IN MICROBIOTAHUMANIZED MICE.. Gastroenterology. 166:S-5. 2024
- 794 GLUTEN DEPENDENT ACTIVATION OF CD4+ T CELLS BY MHC CLASS II EXPRESSING INTESTINAL EPITHELIAL CELLS. Gastroenterology. 166:S-196. 2024
- Tu1655 DISCLOSURE OF DIET TRIGGERS DOES NOT ALTER DIETARY CHOICES IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) AND SELFREPORTED GLUTEN SENSITIVITY. Gastroenterology. 166:S-1367. 2024
- Tu1670 BACTERIAL LYSOPHOSPHATIDYLCHOLINE (LPC) AND LYSOPHOSPHATIDIC ACID (LPA) INDUCE VISCERAL HYPERSENSITIVITY AND LOW-GRADE COLONIC INFLAMMATION IN IRRITABLE BOWEL SYNDROME (IBS). Gastroenterology. 166:S-1373. 2024
- Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment. Digestive and Liver Disease. 56:1805-1809. 2024
- A13 MICROBIOTA FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) INDUCE ALTERED BEHAVIOUR AND VISCERAL HYPERSENSITIVITY IN MICROBIOTA-HUMANIZED MICE. Journal of the Canadian Association of Gastroenterology. 7:7-7. 2024
- A176 RESTORATION OF IMPAIRED MICROBIOTA-MEDIATED ARYL HYDROCARBON RECEPTOR SIGNALING IN PATIENTS WITH CELIAC DISEASE BY ORAL TRYPTOPHAN SUPPLEMENTATION: AN EXPLORATORY STUDY. Journal of the Canadian Association of Gastroenterology. 7:138-139. 2024
- A189 INVESTIGATING THE ROLE OF BACTERIAL HISTAMINE METABOLISM IN VISCERAL HYPERALGESIA. Journal of the Canadian Association of Gastroenterology. 7:148-149. 2024
- A22 INVESTIGATING THE EFFECTS OF DIET TRIGGER DISCLOSURE ON BEHAVIOUR IN IRRITABLE BOWEL SYNDROME (IBS) PATIENTS WITH PERCEIVED GLUTEN SENSITIVITY. Journal of the Canadian Association of Gastroenterology. 7:12-13. 2024
- A41 IDENTIFICATION OF MICROBIAL LYSOPHOSPHATIDYLCHOLINE (LPC) AND LYSOPHOSPHATIDIC ACID (LPA) PRODUCERS AND THEIR EFFECTS ON THE HOST. Journal of the Canadian Association of Gastroenterology. 7:24-25. 2024
- A42 A HIGH SALT DIET INCREASES ELASTOLYTIC ACTIVITY AND WORSENS COLITIS IN GNOTOBIOTIC MICE. Journal of the Canadian Association of Gastroenterology. 7:25-25. 2024
- A6 LYSOPHOSPHATIDYLCHOLINE (LPC) AND LYSOPHOSPHATIDIC ACID (LPA) INDUCE VISCERAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME (IBS). Journal of the Canadian Association of Gastroenterology. 7:3-4. 2024
- A63 RESTRAINED STRESS IN MICE INDUCES TRANSLOCATION OF GUT COMMENSAL BACTERIAL INTO DISTAL ORGANS. Journal of the Canadian Association of Gastroenterology. 7:42-43. 2024
- - Olanzapine and fecal microbiota transplantation from antipsychotic-naïve schizophrenia patients alter metabolic profiles differentially in male and female mice.. Psychoneuroendocrinology. 160:106849-106849. 2024
- Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2.. Gut Microbes. 16:2387857. 2024
- Vasoactive Intestinal Polypeptide Plays a Key Role in the Microbial-Neuroimmune Control of Intestinal Motility. CMGH Cellular and Molecular Gastroenterology and Hepatology. 17:383-398. 2024
- Alterations in fecal β-defensin-3 secretion as a marker of instability of the gut microbiota. Gut Microbes. 15:2233679. 2023
- Crohn’s disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice. Gut Microbes. 15:2205425. 2023
- Diet–microbial cross–talk underlying increased visceral perception. Gut Microbes. 15:2166780. 2023
- Gut microbiota modulates visceral sensitivity through calcitonin gene-related peptide (CGRP) production. Gut Microbes. 15:2188874. 2023
- Changes in signalling from faecal neuroactive metabolites following dietary modulation of IBS pain. Gut. 72:1678-1691. 2023
- The gut protist Tritrichomonas arnold restrains virus-mediated loss of oral tolerance by modulating dietary antigen-presenting dendritic cells. Immunity. 56:1862-1875.e9. 2023
- 1247 REVERSAL OF SEVERE GUT DYSFUNCTION FOLLOWING CLOSTRIDIUM DIFFICILE INFECTION BY MICROBIOTA-DIRECTED DIETARY INTERVENTION. Gastroenterology. 164:s-258-s-259. 2023
- 458 MICROBIOTA FROM PATIENTS WITH CROHN'S DISEASE INDUCES BEHAVIOURAL CHANGES IN MICROBIOTA-HUMANIZED MICE. Gastroenterology. 164:S-87. 2023
- 683 INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY. Gastroenterology. 164:S-136. 2023
- INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY. Gastroenterology. 164:S136-S136. 2023
- MICROBIAL PHOSPHOLIPIDS AS TRIGGERS OF VISCERAL HYPERALGESIA IN IRRITABLE BOWEL SYNDROME. Gastroenterology. 164:S1075-S1075. 2023
- Mo1814 PROTEOLYTIC CROHN'S DISEASE MICROBIOTA ENHANCES INFLAMMATION THROUGH PROTEASE-ACTIVATED RECEPTOR 2 PATHWAY. Gastroenterology. 164:S-921. 2023
- PROTEOLYTIC CROHN'S DISEASE MICROBIOTA ENHANCES INFLAMMATION THROUGH PROTEASE-ACTIVATED RECEPTOR 2 PATHWAY. Gastroenterology. 164:S921-S921. 2023
- Tu1613 ROLE OF GUT MICROBIOTA IN SYMPTOM EPISODES OF IRRITABLE BOWEL SYNDROME. Gastroenterology. 164:S-1057. 2023
- Tu1654 MICROBIAL PHOSPHOLIPIDS AS TRIGGERS OF VISCERAL HYPERALGESIA IN IRRITABLE BOWEL SYNDROME. Gastroenterology. 164:S-1075. 2023
- Understanding neuroimmune interactions in disorders of gut–brain interaction: from functional to immune-mediated disorders. Gut. 72:787-798. 2023
- A19 INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN IRRITABLE BOWEL SYNDROME PATIENTS WITH PERCEIVED GLUTEN SENSITIVITY. Journal of the Canadian Association of Gastroenterology. 6:10-11. 2023
- A265 TEMPORAL DYNAMICS OF SYMPTOMS AND GUT MICROBIOTA IN EPISODES OF IRRITABLE BOWEL SYNDROME. Journal of the Canadian Association of Gastroenterology. 6:83-83. 2023
- A266 DIET-BASED THERAPIES FOR INTESTINAL DYSFUNCTION INDUCED BY CLOSTRIDIOIDES DIFFICILE INFECTION. Journal of the Canadian Association of Gastroenterology. 6:83-84. 2023
- A3 CROHN’S DISEASE PROTEOLYTIC MICROBIOTA ENHANCES INFLAMMATION THROUGH PAR2 PATHWAY IN GNOTOBIOTIC MICE. Journal of the Canadian Association of Gastroenterology. 6:2-2. 2023
- A45 FIBER-FREE DIET REDUCES BACTEROIDES ABUNDANCE AND PREVENTS MUCUS DEGRADATION IN MICE COLONIZED WITH MICROBIOTA FROM PATIENTS WITH GENERALIZED ANXIETY DISORDER. Journal of the Canadian Association of Gastroenterology. 6:25-26. 2023
- A53 FECAL BIOACTIVE PHOSPHOLIPIDS AS TRIGGERS OF INTESTINAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME. Journal of the Canadian Association of Gastroenterology. 6:29-30. 2023
- A62 IDENTIFICATION OF SPECIFIC COLONIC DEEP MUSCLE LAYER MACROPHAGES SUBSETS BY THE CD64 (FCΓRI) MARKER. Journal of the Canadian Association of Gastroenterology. 6:34-34. 2023
- A8 MICROBIAL ACTIVATION OF INTESTINAL DENDRITIC CELLS IS CRITICAL FOR THE ESTABLISHMENT OF NORMAL BEHAVIOR. Journal of the Canadian Association of Gastroenterology. 6:4-5. 2023
- Gut bacteria interact directly with colonic mast cells in a humanized mouse model of IBS. Gut Microbes. 14:2105095. 2022
- Biogeographic Variation and Functional Pathways of the Gut Microbiota in Celiac Disease. Gastroenterology. 163:1351-1363.e15. 2022
- Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice. Science Translational Medicine. 14:eabj1895. 2022
- Mechanisms Underlying Food-Triggered Symptoms in Disorders of Gut-Brain Interactions. American Journal of Gastroenterology. 117:937-946. 2022
- Mo1409: GUT MICROBIOTA MODULATES CGRP PRODUCTION BY DRG NEURONS IN FEMALE MICE. Gastroenterology. 162:S-761. 2022
- Long‐term personalized low FODMAP diet in IBS. Neurogastroenterology and Motility. 34:e14356. 2022
- A13 GUT MICROBIOTA MODULATES CGRP PRODUCTION BY DRG NEURONS IN FEMALE MICE. Journal of the Canadian Association of Gastroenterology. 5:15-17. 2022
- A14 THE INTESTINAL MICROBIOTA CONTRIBUTES TO AGE-RELATED MEMORY DECLINE. Journal of the Canadian Association of Gastroenterology. 5:17-18. 2022
- A144 CHRONIC DSS LEADS TO ALTERED EXPRESSION OF IRAK4/TPL2 PATHWAYS IN UC-COLONIZED MICE. Journal of the Canadian Association of Gastroenterology. 5:17-18. 2022
- A196 DIARRHEA AS A PRESENTING SYMPTOM OF RELAPSED GRANULOMATOSIS WITH POLYANGIITIS. Journal of the Canadian Association of Gastroenterology. 5:81-82. 2022
- A229 GUT MICROBIOTA PROFILES, DIET AND SHORT-CHAIN FATTY ACIDS AS PREDICTORS OF GENERALIZED ANXIETY DISORDER. Journal of the Canadian Association of Gastroenterology. 5:120-121. 2022
- A248 THE ROLE OF DIETARY TRYPTOPHAN IN INDOLE AND KYNURENINE PRODUCTION AND IMMUNE MODULATION IN HEALTHY INDIVIDUALS. Journal of the Canadian Association of Gastroenterology. 5:141-142. 2022
- A34 GLUTEN-FREE DIET IMPROVES DYSPEPTIC SYMPTOMS IN PATIENTS WITH TYPE 1 DIABETES IN WHOM CELIAC DISEASE WAS EXCLUDED. Journal of the Canadian Association of Gastroenterology. 5:40-41. 2022
- A46 BIOGEOGRAPHIC VARIATION AND FUNCTIONAL PATHWAYS OF THE GUT MICROBIOTA IN CELIAC DISEASE. Journal of the Canadian Association of Gastroenterology. 5:53-54. 2022
- A51 ROLE OF GUT MICROBIOTA IN THE EPISODIC NATURE OF SYMPTOMS IN IRRITABLE BOWEL SYNDROME. Journal of the Canadian Association of Gastroenterology. 5:58-60. 2022
- A6 MECHANISMS UNDERLYING GUT DYSFUNCTION FOLLOWING C. DIFFICILE INFECTION AND IMPLICATIONS FOR TREATMENT. Journal of the Canadian Association of Gastroenterology. 5:6-8. 2022
- Purinergic Pathways in the Spinal Microglia as a Putative Target for Treatment of Chronic Abdominal Pain. CMGH Cellular and Molecular Gastroenterology and Hepatology. 13:1257-1258. 2022
- Gut Microbiome and Its Role in the Pathophysiology of Irritable Bowel Syndrome. Acta Gastroenterologica Latinoamericana. 51:378-384. 2021
- Absence of age-related memory decline in germ-free mice. Brain, Behavior, and Immunity. 98:26-26. 2021
- Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG. Clinical Gastroenterology and Hepatology. 19:2343-2352.e8. 2021
- Declining Use of Corticosteroids for Crohn’s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial. Journal of the Canadian Association of Gastroenterology. 4:214-221. 2021
- Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth. Journal of Scleroderma and Related Disorders. 6:290-298. 2021
- Correction to: Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Gastroenterology. 116:1968-1968. 2021
- 735 DORSAL ROOT GANGLIA (DRG) NEURONAL RESPONSES AND SUBSTANCE P PRODUCTION ARE HIGHER IN MALE MICE AND SIMILAR BETWEEN CONVENTIONAL AND GERM-FREE MICE.. Gastroenterology. 160:S-148. 2021
- Sa596 PROINFLAMMATORY EFFECT OF HIGH SALT DIET AND UC MICROBIOTA IN GNOTOBIOTIC MICE. Gastroenterology. 160:s-566-s-567. 2021
- Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis. Gastroenterology. 160:1532-1545. 2021
- A13 A HIGH SALT DIET SYNERGIZES WITH UC MICROBIOTA TO INDUCE A PROINFLAMMATORY IMMUNE TONE IN IMMUNOCOMPETENT GNOTOBIOTIC MICE. Journal of the Canadian Association of Gastroenterology. 4:15-16. 2021
- A238 ABSENCE OF AGE-RELATED MEMORY DECLINE IN GERM-FREE MICE. Journal of the Canadian Association of Gastroenterology. 4:288-289. 2021
- A29 NOVEL FECAL BIOMARKERS THAT PRECEDE CLINICAL DIAGNOSIS OF ULCERATIVE COLITIS. Journal of the Canadian Association of Gastroenterology. 4:268-269. 2021
- A8 DIETARY TRYPTOPHAN MODULATES KYNURENINE AND INDOLE PRODUCTION IN HEALTHY INDIVIDUALS. Journal of the Canadian Association of Gastroenterology. 4:9-10. 2021
- A9 DORSAL ROOT GANGLIA NEURONAL RESPONSES AND SUBSTANCE P PRODUCTION ARE HIGHER IN MALE MICE. Journal of the Canadian Association of Gastroenterology. 4:10-11. 2021
- Saccharomyces boulardii CNCM I‐745 modulates the microbiota–gut–brain axis in a humanized mouse model of Irritable Bowel Syndrome. Neurogastroenterology and Motility. 33:e13985. 2021
- Transcriptional markers of excitation-inhibition balance in germ-free mice show region-specific dysregulation and rescue after bacterial colonization. Journal of Psychiatric Research. 135:248-255. 2021
- The Risk of Contracting COVID-19 Is Not Increased in Patients With Celiac Disease. Clinical Gastroenterology and Hepatology. 19:391-393. 2021
- Derivation and validation of a novel method to subgroup patients with functional dyspepsia: beyond upper gastrointestinal symptoms. Alimentary Pharmacology and Therapeutics. 53:253-264. 2021
- Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation. Science Translational Medicine. 12:eaba0624. 2020
- Nutritional profile of rodent diets impacts experimental reproducibility in microbiome preclinical research. Scientific Reports. 10:17784. 2020
- IMAGINE Network’s Mind And Gut Interactions Cohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndrome. BMJ Open. 10:e041733-e041733. 2020
- Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Gastroenterology. 115:1584-1595. 2020
- The gut microbiome and inflammation in obsessive‐compulsive disorder patients compared to age‐ and sex‐matched controls: a pilot study. Acta Psychiatrica Scandinavica. 142:337-347. 2020
- Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis. Gastroenterology. 159:884-903.e31. 2020
- AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology. 159:697-705. 2020
- Spotlight: Probiotics Guidelines. Gastroenterology. 159:707-707. 2020
- Evidence-based and mechanistic insights into exclusion diets for IBS. Nature Reviews Gastroenterology and Hepatology. 17:406-413. 2020
- Screening and Treatment Outcomes in Adults and Children With Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study. Diabetes Reviews. 43:1553-1556. 2020
- Application of metabolomics to the study of irritable bowel syndrome. Neurogastroenterology and Motility. 32:e13884. 2020
- The Brain-Gut-Microbiome Axis and Irritable Bowel Syndrome.. Gastroenterology and Hepatology. 16:322-324. 2020
- 1123 ARYL HYDROCARBON RECEPTOR LIGAND PRODUCTION BY THE GUT MICROBIOTA IN CELIAC DISEASE. Gastroenterology. 158:S-217. 2020
- 715 SACCHAROMYCES BOULARDII CNCM I-745 IMPROVES GUT-BRAIN AXIS DYSFUNCTION IN A HUMANIZED MOUSE MODEL OF IRRITABLE BOWEL SYNDROME WITH CO-MORBID ANXIETY. Gastroenterology. 158:S-150. 2020
- Mo1570 THE INTESTINAL MICROBIOTA FROM A PATIENT WITH IBS-C SLOWS MOUSE COLONIC TRANSIT BY DISRUPTING INTERSTITIAL CELL OF CAJAL NETWORK. Gastroenterology. 158:s-899-s-900. 2020
- Su1218 EVALUATION OF GUT MICROBIOTA COMPOSITION IN NAFLD WITH UC PANCOLITIS IN CLINICAL REMISSION: A PILOT STUDY. Gastroenterology. 158:s-547-s-548. 2020
- Su1234 THE INFLUENCE OF SEX AND THE GUT MICROBIOTA ON VISCERAL SENSITIVITY IN MICE. Gastroenterology. 158:S-553. 2020
- Su1853 CHARACTERISTICS OF SKIN LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY OR OTHER BIOLOGIC AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY. Gastroenterology. 158:s-675-s-676. 2020
- Tu1006 THE ASSOCIATION BETWEEN INFLAMMATORY BOWEL DISEASE AND CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology. 158:s-1002-s-1003. 2020
- Tu1938 PROBIOTICS FOR CELIAC DISEASE: A SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Gastroenterology. 158:S-1225. 2020
- A108 PROBIOTICS FOR CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Journal of the Canadian Association of Gastroenterology. 3:125-126. 2020
- A11 MICROBIAL AND METABOLOMIC PROFILES IDENTIFY SUBSETS OF DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME. Journal of the Canadian Association of Gastroenterology. 3:13-15. 2020
- A118 GUT MICROBIOTA TRANSPLANTATION FROM A PATIENT WITH SEVERE CONSTIPATION INDUCED CHANGES IN COLONIC FUNCTION AND STRUCTUR OF GNOTOBIOTIC MICE. Journal of the Canadian Association of Gastroenterology. 3:137-138. 2020
- A122 THE INFLUENCE OF SEX AND THE GUT MICROBIOTA ON VISCERAL PAIN SENSITIVITY IN MICE. Journal of the Canadian Association of Gastroenterology. 3:142-143. 2020
- A131 MALNUTRITION FOLLOWING IMPLEMENTATION OF A STRICT LOW FODMAP DIET FOR IBS. Journal of the Canadian Association of Gastroenterology. 3:151-152. 2020
- A193 GLUTEN-FREE DIET IMPROVES DYSPEPSIA-LIKE SYMPTOMS IN A PILOT STUDY OF PATIENTS WITH TYPE 1 DIABETES MELLITUS. Journal of the Canadian Association of Gastroenterology. 3:64-65. 2020
- A194 PRESENCE OF CELIAC DISEASE IN PATIENTS WITH BARRETT’S ESOPHAGUS IS ASSOCIATED WITH FASTER DEVELOPMENT OF DYSPLASIA AND HIGHER RATES OF ESOPHAGEAL ADENOCARCINOMA. Journal of the Canadian Association of Gastroenterology. 3:65-66. 2020
- A22 ADVERSE EARLY LIFE EVENTS ARE COMMON IN PATIENTS WITH FUNCTIONAL AND ORGANIC GASTROINTESTINAL DISORDERS. Journal of the Canadian Association of Gastroenterology. 3:26-27. 2020
- A261 MICROBIOTA PROFILES OF PATIENTS WITH MENTAL DISODERS DIFFER FROM THOSE OF HEALTHY CONTROLS. Journal of the Canadian Association of Gastroenterology. 3:138-139. 2020
- A42 MICROBIAL METABOLISM OF DIETARY TRYPTOPHAN ENHANCES ARYL HYDROCARBON RECEPTOR ACTIVATION: IMPLICATIONS FOR IBD. Journal of the Canadian Association of Gastroenterology. 3:50-51. 2020
- A43 β-DEFENSINS AS MARKERS OF INTESTINAL DYSBIOSIS: THE NATURE OF CHANGES IN β-DEFENSINS IS DEPENDENT ON THE PROCESS UNDERLYING THE INDUCTION OF DYSBIOSIS. Journal of the Canadian Association of Gastroenterology. 3:51-52. 2020
- A50 TRANSFER OF DEPRESSIVE-LIKE PHENOTYPE TO GNOTOBIOTIC MICE DEPENDS ON MICROBIAL FEATURES SPECIFIC TO INDIVIDUAL PATIENTS. Journal of the Canadian Association of Gastroenterology. 3:59-60. 2020
- A53 SACCHAROMYCES BOULARDII CNCM I-745 IMPROVES ANXIETY-LIKE BEHAVIOR AND RESCUES DYSMOTILITY IN A HUMANIZED MOUSE MODEL OF IRRITABLE BOWEL SYNDROME WITH CO-MORBID ANXIETY. Journal of the Canadian Association of Gastroenterology. 3:62-63. 2020
- A55 LACK OF EXPERIMENTAL REPRODUCIBILITY IN PRECLINICAL RESEARCH IS INFLUENCED BY THE NUTRITIONAL PROFILE OF STANDARD RODENT CHOWS. Journal of the Canadian Association of Gastroenterology. 3:64-65. 2020
- P841 Evaluation of gut microbiota composition in NAFLD with UC pancolitis in clinical remission: a pilot study. Journal of Crohn's and Colitis. 14:S650-S651. 2020
- Investigation of the Gut Microbiome in Patients with Schizophrenia and Clozapine-Induced Weight Gain: Protocol and Clinical Characteristics of First Patient Cohorts. Neuropsychobiology. 79:5-12. 2020
- Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder. Journal of Psychiatric Research. 118:1-6. 2019
- Abstract #4379 Microbial composition and restraint stress induce anxiety-like behavior related to inflammation and GABA signaling along the gut-brain axis of mice. Brain, Behavior, and Immunity. 81:48-48. 2019
- Response to Letter by Moulton et al.. Inflammatory Bowel Diseases. 25:e99-e99. 2019
- Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 25:1255-1261. 2019
- Lactobacilli Degrade Wheat Amylase Trypsin Inhibitors to Reduce Intestinal Dysfunction Induced by Immunogenic Wheat Proteins. Gastroenterology. 156:2266-2280. 2019
- Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients. Metabolomics. 15:82. 2019
- 819 – Metabolism of Wheat Amylase Trypsin Inhibitors by Lactobacilli Ameliorates Gut Dysfunction Induced by Wheat Proteins. Gastroenterology. 156:s-174-s-175. 2019
- 877 – Microbiota Plays a Key Role in Formation of Normal Intestinal Motor Patterns. Gastroenterology. 156:S-198. 2019
- Sa2038 – Lack of Experimental Reproducibility in Preclinical Research May Be Influenced by the Nutritional Profile of Standard Rodent Chows. Gastroenterology. 156:S-481. 2019
- Su1580 – A Longitudinal Study Examining the Effect of Altering Fodmap Intake on the Metabolome and Pain Signalling in IBS Patients. Gastroenterology. 156:s-570-s-571. 2019
- Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission – confounded by the gut microbiome? Authors’ reply. Alimentary Pharmacology and Therapeutics. 49:1088-1089. 2019
- A136 A LONGITUDINAL STUDY EXAMINING FODMAP INTAKE AND THE METABOLOME IN IBS PATIENTS. Journal of the Canadian Association of Gastroenterology. 2:271-272. 2019
- A139 A LOW FODMAP DIET REDUCES SYMPTOMS IN INDIVIDUAL IBS PATIENTS BUT NOT MUCOSAL IMMUNE ACTIVATION OF NOCICEPTORS. Journal of the Canadian Association of Gastroenterology. 2:277-278. 2019
- A149 EARLY LIFE EVENTS IN PATIENTS WITH CELIAC DISEASE ARE COMMON AND ASSOCIATE WITH SEVERITY OF CONSTIPATION IN ADULTHOOD.. Journal of the Canadian Association of Gastroenterology. 2:296-296. 2019
- A173 LACK OF EXPERIMENTAL REPRODUCIBILITY IN PRECLINICAL RESEARCH: FOCUS ON DIETARY CONTENT OF FERMENTABLE CARBOHYDRATE (FODMAPS) IN STANDARD RODENT CHOWS. Journal of the Canadian Association of Gastroenterology. 2:340-341. 2019
- A32 THE ROLE OF GUT MICROBIOTA AND TRACE AMINES IN A MURINE MODEL OF GENERALIZED ANXIETY DISORDER. Journal of the Canadian Association of Gastroenterology. 2:64-65. 2019
- A46 FECAL β-DEFENSIN LEVELS AS A RELIABLE BIOMARKER OF INTESTINAL DYSBIOSIS. Journal of the Canadian Association of Gastroenterology. 2:92-93. 2019
- A49 LACTOBACILLI DEGRADE WHEAT AMYLASE TRYPSIN INHIBITORS (ATI) TO AMELIORATE GUT DYSFUNCTION INDUCED BY IMMUNOGENIC WHEAT PROTEINS. Journal of the Canadian Association of Gastroenterology. 2:97-98. 2019
- A50 MICROBIOTA-MAST CELL INTERACTIONS IN A HUMANIZED MOUSE MODEL OF IBS. Journal of the Canadian Association of Gastroenterology. 2:99-100. 2019
- A59 EXPLORING THE ROLE OF MICROBIOTA IN GASTROINTESTINAL MOTILITY. Journal of the Canadian Association of Gastroenterology. 2:118-119. 2019
- Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nature Communications. 10:1198. 2019
- Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers. Alimentary Pharmacology and Therapeutics. 49:723-732. 2019
- Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. Gastroenterology. 156:46-58.e7. 2019
- Small-Molecule Allosteric Triggers of Clostridium difficile Toxin B Auto-proteolysis as a Therapeutic Strategy. Cell Chemical Biology. 26:17-26.e13. 2019
- High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production. Microbiome. 6:57. 2018
- Beliefs and Practices of Canadian and U.S. Physicians Regarding the Use of Probiotics for Gastrointestinal Illnesses. American Journal of Gastroenterology. 113:S253-S253. 2018
- 1018 - Microbiota from Ibs-D Patients Induces Dysregulation of Innate Immunity. Gastroenterology. 154:S-193. 2018
- 916 - Gut Microbiota-Diet Interactions in a Humanized Mouse Model of IBS: The Role of Intestinal Mast Cells. Gastroenterology. 154:S-182. 2018
- Mo1039 - The Prevalence of Celiac Disease is Increased in Patients with Barrett's Esophagus and is Associated with Early Development of Dysplasia. Gastroenterology. 154:S-680. 2018
- Su1658 - Gut Microbiota Defines Host Responses to Dietary Fermentable Carbohydrates in IBS: The Role of Bacterial Histamine. Gastroenterology. 154:S-565. 2018
- A20 GUT MICROBIOTA-DIET INTERACTION ALTER INTESTINAL MAST CELL NUMBERS AND DISTRIBUTION IN THE HUMANIZED IBS MOUSE MODEL. Journal of the Canadian Association of Gastroenterology. 1:33-34. 2018
- A21 FERMENTABLE CARBOHYDRATE-MICROBIOME INTERACTIONS IN A MOUSE MODEL OF IBS. Journal of the Canadian Association of Gastroenterology. 1:35-36. 2018
- A263 IBS-D MICROBIOTA INDUCES GUT-BRAIN DYSFUNCTION BY DISRUPTING INTESTINAL NEURAL AND IMMUNE PATHWAYS. Journal of the Canadian Association of Gastroenterology. 1:458-458. 2018
- A266 AMYLASE TRYPSIN INHIBITORS FROM WHEAT EXACERBATE GLUTEN-INDUCED PATHOLOGY AND ALTER GUT MICROBIOTA IN MICE. Journal of the Canadian Association of Gastroenterology. 1:462-462. 2018
- A279 COLONIZATION WITH PROTEOLYTIC BACTERIA INDUCES LOW-GRADE INFLAMMATION AND BARRIER DYSFUNCTION IN MICE. Journal of the Canadian Association of Gastroenterology. 1:404-404. 2018
- A281 EFFECT OF A GLUTEN FREE DIET ON SYMPTOMS IN IBS PATIENTS STRATIFIED BY ANTIGLIADIN ANTIBODIES. Journal of the Canadian Association of Gastroenterology. 1:488-488. 2018
- A284 CHARACTERIZING SIMULTANEOUS PRESSURE WAVES IN THE HUMAN COLON BY HIGH-RESOLUTION MANOMETRY. Journal of the Canadian Association of Gastroenterology. 1:409-410. 2018
- A287 REACTIVITY OF THE EXTRINSIC AUTONOMIC NERVOUS SYSTEM ASSOCIATED WITH HUMAN COLONIC MOTOR PATTERNS. Journal of the Canadian Association of Gastroenterology. 1:413-414. 2018
- A288 ANAL SPHINCTER RELAXATION ASSOCIATED WITH THE DEFECATION REFLEX AND GAS EXPULSION, ASSESSED BY HIGH-RESOLUTION COLONIC MANOMETRY. Journal of the Canadian Association of Gastroenterology. 1:415-416. 2018
- A294 ROLE OF MACROPHAGE IN GUT MICROBIOTA-BRAIN SIGNALING. Journal of the Canadian Association of Gastroenterology. 1:510-510. 2018
- A296 A RHYTHMIC MOTOR PATTERN ASSOCIATED WITH HIGH AMPLITUDE PRESSURE WAVES IN HUMAN HIGH-RESOLUTION COLONIC MANOMETRY. Journal of the Canadian Association of Gastroenterology. 1:425-426. 2018
- A297 FREQUENT ADVERSE CHILDHOOD EVENTS IN PATIENTS WITH IBS AND ORGANIC GASTROINTESTINAL DISORDERS. Journal of the Canadian Association of Gastroenterology. 1:427-427. 2018
- A300 DIET-MICROBIOTA INTERACTIONS UNDERLIE SYMPTOMS IN IBS. Journal of the Canadian Association of Gastroenterology. 1:521-522. 2018
- A301 GUT MICROBIOTA FROM A PATIENT WITH GENERALIZED ANXIETY DISORDER INDUCES ANXIETY-LIKE BEHAVIOUR AND ALTERED BRAIN CHEMISTRY IN GNOTOBIOTIC MICE. Journal of the Canadian Association of Gastroenterology. 1:523-524. 2018
- A303 SIMULTANEOUS PRESSURE WAVES ARE A KEY COMPONENT OF HUMAN COLON MOTOR FUNCTION ASSESSMENT, USING HIGH-RESOLUTION COLONIC MANOMETRY (HRCM). Journal of the Canadian Association of Gastroenterology. 1:527-528. 2018
- A67 RAPID REDUCTION IN ANXIETY SCORES IN IBD PATIENTS AFTER INFLIXIMAB INFUSION IS ASSOCIATED WITH CHANGES IN KYNURENINE/TRYPTOPHAN METABOLISM. Journal of the Canadian Association of Gastroenterology. 1:106-106. 2018
- Reply. Gastroenterology. 154:764-765. 2018
- Characterization of Simultaneous Pressure Waves as Biomarkers for Colonic Motility Assessed by High-Resolution Colonic Manometry. Frontiers in Physiology. 9:1248. 2018
- Proton pump inhibitors for functional dyspepsia. Cochrane Database of Systematic Reviews. 2018:CD011194. 2017
- Bifidobacterium infantis NLS Super Strain Reduces the Expression of α-Defensin-5, a Marker of Innate Immunity, in the Mucosa of Active Celiac Disease Patients. Journal of Clinical Gastroenterology. 51:814-817. 2017
- Impact ofβ2-1 fructan on faecal community change: results from a placebo-controlled, randomised, double-blinded, cross-over study in healthy adults. British Journal of Nutrition. 118:441-453. 2017
- Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology. 153:448-459.e8. 2017
- Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. Gastroenterology. 153:395-409.e3. 2017
- FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. 66:1241-1251. 2017
-
Editorial: latent class analysis to improve confidence in the diagnosis of
IBS – authors’ reply. Alimentary Pharmacology and Therapeutics. 45:1268-1269. 2017 - Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia. Scandinavian Journal of Gastroenterology, Supplement. 52:396-402. 2017
- Antigliadin Antibodies Predict the Symptomatic Response to Gluten-Free Diet and Improvement in Gastrointestinal Motility in IBS Patients. Gastroenterology. 152:S45-S45. 2017
-
Letter:
NICE referral criteria for lower gastrointestinal alarm features – not ideal but not poor either. Authors' reply. Alimentary Pharmacology and Therapeutics. 45:1176-1176. 2017 - β2‐1 Fructan Supplementation in Healthy Adults Elicits Host‐Specific Bacterial Responses But Does Not Support a Defined Health Benefit. The FASEB Journal. 31. 2017
- Proton pump inhibitors for functional dyspepsia. Cochrane Database of Systematic Reviews. 3:CD011194. 2017
- Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis. Alimentary Pharmacology and Therapeutics. 45:824-832. 2017
- No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease. Gastroenterology. 152:787-798.e2. 2017
- Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Science Translational Medicine. 9:eaaf6397. 2017
- Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care. Alimentary Pharmacology and Therapeutics. 45:91-99. 2017
- Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling. Genome Medicine. 8:72. 2016
- Acetylcholine-producing T cells in the intestine regulate antimicrobial peptide expression and microbial diversity. American Journal of Physiology - Gastrointestinal and Liver Physiology. 311:G920-G933. 2016
- SHP‐2 Phosphatase Prevents Colonic Inflammation by Controlling Secretory Cell Differentiation and Maintaining Host‐Microbiota Homeostasis. Journal of Cellular Physiology. 231:2529-2540. 2016
- Tracking gastrointestinal transit of solids in aged rats as pharmacological models of chronic dysmotility. Neurogastroenterology and Motility. 28:1241-1251. 2016
- β2-1 Fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: results from a double-blinded, randomised, cross-over study in healthy adults. British Journal of Nutrition. 115:1748-1759. 2016
- Using a Welding Robot for Small-Batch Production. Welding Journal. 95:54-58. 2016
- Altered Esophageal Mucosal Structure in Patients with Celiac Disease. Canadian Journal of Gastroenterology and Hepatology. 2016:1-9. 2016
- Gluten Introduction to Infant Feeding and Risk of Celiac Disease: Systematic Review and Meta-Analysis. Journal of Pediatrics. 168:132-143.e3. 2016
-
Program and Abstracts from the Canadian Digestive Diseases Week
- Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiology. 15:67. 2015
- Adrenergic innervation regulates intestinal microbiota diversity via generation of cholinergic Th17 lymphocytes. Autonomic Neuroscience: Basic and Clinical. 192:58-58. 2015
- Functional impact of IBS-D microbiota on the gut-brain axis. Brain, Behavior, and Immunity. 49:e41-e41. 2015
- Lost in Translation: The Gut Microbiota in Psychiatric Illness. Canadian Journal of Psychiatry. 60:460-463. 2015
- The role of immune system maturation in gut-microbiota-brain axis communication. Brain, Behavior, and Immunity. 49:e36-e37. 2015
- Contact Allergy in Atopic Patients: What We Suspected and What We Know. Current Treatment Options in Allergy. 2:246-256. 2015
- Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model. Inflammatory Bowel Diseases. 21:1883-1893. 2015
- Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nature Communications. 6:7735. 2015
- Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scandinavian Journal of Gastroenterology, Supplement. 50:816-823. 2015
- Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency. American Journal of Gastroenterology. 110:1038-1048. 2015
- No increase in prevalence of somatization in functional vs organic dyspepsia: a cross‐sectional survey. Neurogastroenterology and Motility. 27:1024-1031. 2015
- Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID. American Journal of Physiology - Gastrointestinal and Liver Physiology. 308:G994-G1003. 2015
- Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial. Gastroenterology. 148:1311-1319.e6. 2015
- Lack of Utility of Symptoms and Signs at First Presentation as Predictors of Inflammatory Bowel Disease in Secondary Care. American Journal of Gastroenterology. 110:716-724. 2015
- 73 Adrenergic Innervation Regulates Intestinal Microbiota Diversity and Richness via Cholinergic Th17 Lymphocytes. Gastroenterology. 148:S-20. 2015
- Mo1263 Anxiety and Depression Increase in a Step-Wise Fashion in Parallel With Multiple FGIDs. Gastroenterology. 148:S-654. 2015
- Mo1326 Increased Risk of Functional Gastrointestinal Disorders (FGIDs) in Obesity Patients. Gastroenterology. 148:s-672-s-673. 2015
- NSAID enteropathy and bacteria: a complicated relationship. Journal of Gastroenterology. 50:387-393. 2015
- Sa1295 Reflux Symptoms in Patients With Celiac Disease Are Associated With Alkaline or Weakly Acid Reflux. Gastroenterology. 148:S-284. 2015
- Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating. Alimentary Pharmacology and Therapeutics. 41:449-458. 2015
-
Hydrogen sulphide protects against
NSAID ‐enteropathy through modulation of bile and the microbiota. British Journal of Pharmacology. 172:992-1004. 2015 - Extraintestinal Manifestations of Celiac Disease. Digestive Diseases. 33:147-154. 2015
- Motility Alterations in Celiac Disease and Non-Celiac Gluten Sensitivity. Digestive Diseases. 33:200-207. 2015
- Tax-Deductible Provisions for Gluten-Free Diet in Canada Compared with Systems for Gluten-Free Diet Coverage Available in Various Countries. Canadian Journal of Gastroenterology and Hepatology. 29:104-110. 2015
- Bead study: a novel method to measure gastrointestinal transit in mice. Neurogastroenterology and Motility. 26:1663-1668. 2014
- The microbiota–gut–brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?. Journal of Physiology. 592:2989-2997. 2014
- Proton pump inhibitors for functional dyspepsia. Clinical Respiratory Journal. 2014. 2014
- 24 The Critical Role of Gut Microbiota in Determining Behavioral Changes and Susceptibility to Inflammation in a Model of Depression. Gastroenterology. 146:S-7. 2014
- 29 The Effect of High Fat Diet on Human Microbiota Transfer Into Gnotobiotic Mice. Gastroenterology. 146:s-8-s-9. 2014
- 81 Transplantation of Dysbiotic Microbiota Derived From UC Patients Promotes a Pro-Inflammatory Phenotype and Increased Susceptibility of Gnotobiotic Mice to Colitis. Gastroenterology. 146:S-23. 2014
- 929b Larazotide Acetate, a First In-Class, Novel Tight Junction Regulator, Meets Primary Endpoint and Significantly Reduces Signs and Symptoms of Celiac Disease in Patients on a Gluten-Free Diet: Results of a Multicenter, Randomized, Placebo Controlled Trial. Gastroenterology. 146:S-159. 2014
- Mo1197 Dermatological Complications of Anti-TNF-a Therapy in Crohn's Disease. Gastroenterology. 146:S-583. 2014
- Su1444 Increased Prevalence of Gluten Related Disorders in Patients With Barrett's Esophagus: The Impact on the Development of Dysplasia. Gastroenterology. 146:s-470-s-471. 2014
- The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes. 5:419-429. 2014
- Tu1778 Faecalibacterium prausnitzii Prevents Irritable Bowel Syndrome-Like Symptoms in Both Murine Low Grade Chronic Inflammation and Acute Stress Models. Gastroenterology. 146:s-840-s-841. 2014
- Tu1797 The Adoptive Transfer of Anxiety and Gut Dysfunction From IBS Patients to Axenic Mice Through Microbiota Transplantation. Gastroenterology. 146:S-845. 2014
- The Rome III Criteria for the Diagnosis of Functional Dyspepsia in Secondary Care Are Not Superior to Previous Definitions. Gastroenterology. 146:932-940.e1. 2014
- The Commensal Bacterium Faecalibacterium prausnitzii Is Protective in DNBS-induced Chronic Moderate and Severe Colitis Models. Inflammatory Bowel Diseases. 20:417-430. 2014
- Characteristics of functional bowel disorder patients: a cross‐sectional survey using the Rome III criteria. Alimentary Pharmacology and Therapeutics. 39:312-321. 2014
- The origin of segmentation motor activity in the intestine. Nature Communications. 5:3326. 2014
- Differential Induction of Antimicrobial REGIII by the Intestinal Microbiota and Bifidobacterium breve NCC2950. Applied and Environmental Microbiology. 79:7745-7754. 2013
- Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Gastroenterology. 145:1262-1270.e1. 2013
- Erratum. Neurogastroenterology and Motility. 25:857-857. 2013
- Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterology and Motility. 25:733-733. 2013
- Intestinal bacteria influence brain activity in healthy humans. Nature Reviews Gastroenterology and Hepatology. 10:326-327. 2013
- The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Current Opinion in Microbiology. 16:240-245. 2013
- Tu1974 Bifidobacterium Breve NCC2950 Induces Expression of Antimicrobial Regiii in Colonic Epithelial Cells Through MYD88-Ticam Pathway. Gastroenterology. 144:s-894-s-895. 2013
- Tu1988 Impact of the Commensal Bacterium Faecalibacterium prausnitzii in a Non Active Inflammation Murine Model. Gastroenterology. 144:s-897-s-898. 2013
- ILSI Brazil International Workshop on Functional Foods: a narrative review of the scientific evidence in the area of carbohydrates, microbiome, and health. Food and Nutrition Research. 57:19214-19214. 2013
- The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes. 4:17-27. 2013
- The interplay between the intestinal microbiota and the brain. Nature Reviews Microbiology. 10:735-742. 2012
- Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells. Laboratory Investigation. 92:937-948. 2012
- 308 Immediate Effects of Infliximab Infusion on Mood in Patients With Inflammatory Bowel Disease. Gastroenterology. 142:S-69. 2012
- Microbes and the gut‐brain axis. Neurogastroenterology and Motility. 24:405-413. 2012
- Sa2061 Protective and Curative Effect of Faecalibacterium prausnitzii in a Chronic DNBS-Induced Murine Colitis. Gastroenterology. 142:S-392. 2012
- Su1990 The Role of Microbiota in the Maternal Separation Model of Depression. Gastroenterology. 142:S-554. 2012
- Tu1997 A Novel In Vivo Method to Measure Gastrointestinal Transit in Mice. Gastroenterology. 142:S-897. 2012
- Targeting the microbiota–gut–brain axis to modulate behavior: Which bacterial strain will translate best to humans?. Proceedings of the National Academy of Sciences of the United States of America. 109:E174. 2012
- The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterology and Motility. 23:1132-1139. 2011
- Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis. Gastroenterology. 141:1314-1322.e5. 2011
- The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice. Gastroenterology. 141:599-609.e3. 2011
- Characterizing the Neural Pathways of Communication Within the Microbiota-Gut-Brain Axis. Gastroenterology. 140:S-362. 2011
- Proton Pump Inhibitors and Low-Dose Aspirin Markedly Exacerbate NSAID-Induced Small Intestinal Injury: A Link to Dysbiosis?. Gastroenterology. 140:S-87. 2011
- The Intestinal Microbiota Determines Mouse Behavior and Brain BDNF Levels. Gastroenterology. 140:S-57. 2011
- The microbiota-gut-brain axis: learning from intestinal bacteria?. Gut. 60:288-289. 2011
- Epidemiology and Burden of Chronic Constipation. Canadian Journal of Gastroenterology and Hepatology. 25:11b-15b. 2011
- Epidemiology and Burden of Chronic Constipation. Canadian Journal of Gastroenterology and Hepatology. 25:11B-15B. 2011
- Chronic Gastrointestinal Inflammation Induces Anxiety-Like Behavior and Alters Central Nervous System Biochemistry in Mice. Gastroenterology. 139:2102-2112.e1. 2010
- Pathogenic Factors Involved in the Development of Irritable Bowel Syndrome: Focus on a Microbial Role. Infectious Disease Clinics of North America. 24:961-975. 2010
- Spontaneous Intramural Esophageal Hematoma in Association With Idiopathic Thrombocytopenic Purpura: A Cause of Non-Cardiac Chest Pain. Clinical Gastroenterology and Hepatology. 8:e73-e74. 2010
- The Influence of Commensal Bacteria on the Gut-Brain Axis: Implications for Understanding and Treating Functional GI Disorders. Bioscience of Microbiota, Food and Health. 29:179-183. 2010
- The putative role of the intestinal microbiota in the irritable bowel syndrome. Digestive and Liver Disease. 41:850-853. 2009
- Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism. Science. 325:617-620. 2009
- Review: Effect of probiotics on gastrointestinal function: evidence from animal models. Therapeutic Advances in Gastroenterology. 2:S31-S35. 2009
- S1801 Neonatal Stress Induces Changes in the Enteric Nervous System and Gut Microflora. Gastroenterology. 136:A-273. 2009
- T1767 Examination of the Depressed Gut Reveals Changes in Microbiota and Serotonin Levels. Gastroenterology. 136:A-575. 2009
- The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease. Gastroenterology. 136:2003-2014. 2009
- W1618 Early Depression-Like Behaviour in Maternal Separation Mice Is Associated with Altered Microbiota. Gastroenterology. 136:A-703. 2009
- W2031 Antibiotic-Induced Intestinal Dysbiosis Results in Altered Behavior in BALB/C Mice. Gastroenterology. 136:a-776-a-777. 2009
- Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. American Journal of Physiology. Regulatory Integrative and Comparative Physiology. 296:R587-R594. 2009
- The Role of Pathogenic Microbes and Commensal Bacteria in Irritable Bowel Syndrome. Digestive Diseases. 27:85-89. 2009
- The role of luminal factors in the recovery of gastric function and behavioral changes after chronicHelicobacter pyloriinfection. American Journal of Physiology - Gastrointestinal and Liver Physiology. 295:G664-G670. 2008
- 694 Effects of Probiotics On Gut-Brain Axis During Chronic H. pylori Infection. Gastroenterology. 134:A-97. 2008
- W1377 Altered Intestinal Paracellular Permeability in H. pylori Infected Mice Is Restored By Bacterial Eradication and Probiotic Treatment. Gastroenterology. 134:A-691. 2008
- Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut. 56:358-364. 2007
- C-13 urea breath test for Helicobacter pylori: Determination of the optimal cut-off point in a Canadian community population. Canadian Journal of Gastroenterology and Hepatology. 20:770-774. 2006
- C-13 urea breath test for Helicobacter pylori: Evaluation of 10-minute breath collection. Canadian Journal of Gastroenterology and Hepatology. 20:775-778. 2006
- Antidepressants Attenuate Increased Susceptibility to Colitis in a Murine Model of Depression. Gastroenterology. 130:1743-1753. 2006
- CD4+ T-Cell Modulation of Visceral Nociception in Mice. Gastroenterology. 130:1721-1728. 2006
- LACTOBACILLUS PARACASEI NORMALIZES POST‐INFECTIVE DYSMOTILITY IN VIVO ‐ POTENTIAL MECHANISMS INVOLVED. Journal of Pediatric Gastroenterology and Nutrition. 42:e96-e96. 2006
- Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut. 55:182-190. 2006
- 13C Urea Breath Test for Helicobacter pylori: Determination of the Optimal Cut-Off Point in a Canadian Community Population. Canadian Journal of Gastroenterology. 20:770-774. 2006
- 13C Urea Breath Test forHelicobacter pylori: Evaluation of 10-minute Breath Collection. Canadian Journal of Gastroenterology. 20:775-778. 2006
- Lack of pyloric interstitial cells of Cajal explains distinct peristaltic motor patterns in stomach and small intestine. American Journal of Physiology - Gastrointestinal and Liver Physiology. 289:G539-G549. 2005
- Noninvasive Verification of Nasogastric Tube Placement Using a Magnet‐Tracking System: A Pilot Study in Healthy Subjects. Journal of Parenteral and Enteral Nutrition. 29:305-310. 2005
- TGF-β1 gene transfer to the mouse colon leads to intestinal fibrosis. American Journal of Physiology - Gastrointestinal and Liver Physiology. 289:G116-G128. 2005
- Is Irritable Bowel Syndrome a Low-Grade Inflammatory Bowel Disease?. Gastroenterology Clinics of North America. 34:235-245. 2005
- Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology. 127:826-837. 2004
- Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology. 127:179-187. 2004
- Microbial-gut interactions in health and disease. Irritable bowel syndrome.. Best Practice and Research in Clinical Gastroenterology. 18:315-321. 2004
- Adenoviral Transfer of the Murine Oncostatin M Gene Suppresses Dextran-Sodium Sulfate-Induced Colitis. Journal of Interferon and Cytokine Research. 23:193-201. 2003
- Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology. 123:1205-1215. 2002
- Modulatory effects of estrogen in two murine models of experimental colitis. American Journal of Physiology - Gastrointestinal and Liver Physiology. 283:G27-G36. 2002
- Pathology of Interstitial Cells of Cajal in Relation to Inflammation Revealed by Ultrastructure But Not Immunohistochemistry. American Journal of Pathology. 160:1529-1540. 2002
- Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice. Clinical and Experimental Immunology. 120:46-50. 2001
- Chronic H. pylori interaction induces functional and morphological changes in the neural system. Gastroenterology. 120:A235-A235. 2001
- In Vivo motility disturbances in a model of post-infective IBS. Gastroenterology. 120:A71-A71. 2001
- Neuro-immune interactions in the stomach of H. pylori infected mice: Role of lymphocytes. Gastroenterology. 120:A535-A535. 2001
- Development of interstitial cells of Cajal in a full-term infant without an enteric nervous system. Gastroenterology. 120:561-567. 2001
- Response To Dr. Mccoll et al.. American Journal of Gastroenterology. 96:602-604. 2001
- Organization of intestinal pacemakers. Gastroenterology. 120:319-320. 2001
- Organization of intestinal pacemakers - Reply. Gastroenterology. 120:320-321. 2001
- Reply. Gastroenterology. 120:320-321. 2001
- Interstitial cells of Cajal and inflammation-induced motor dysfunction in the mouse small intestine. Gastroenterology. 119:1590-1599. 2000
- Quantitative analysis of intestinal motor patterns: Spatiotemporal organization of nonneural pacemaker sites in the rat ileum. Gastroenterology. 119:386-394. 2000
- The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection. American Journal of Gastroenterology. 95:947-955. 2000
- Omeprazole:Helicobacter pylori makes thee greater yet. Gut. 44:448-449. 1999
- High Concentrations of Ammonia, But Not Volatile Amines, in Gastric Juice of Subjects with Helicobacter pylori Infection. Helicobacter. 3:97-102. 1998
- Letters to the Editors. Alimentary Pharmacology and Therapeutics. 12:395-396. 1998
- Reflux esophagitis and H. pylori.. Gastroenterology. 113:2020-2021. 1997
- Helicobacter pylori infection and omeprazole efficacy. Gastroenterology. 111:1401-1403. 1996
- Origins of motility patterns in isolated arterially perfused rat intestine. Gastroenterology. 106:649-657. 1994
- VIEWS OF A SENIOR STUDENT. Nursing Forum. 8:127-131. 1969
-
preprints